Donald Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Massachusetts College of Pharmacy and Health SciencesPharmD, 2012
Publications & Presentations
PubMed
- 1 citationsTafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis.Donald C Moore, Keren A Eagers, Amanda Janes, Mauricio Pineda-Roman
Journal of Oncology Pharmacy Practice. 2023-01-01 - 5 citationsNew and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma.Donald C Moore, Matthew R Peery, Katherine A Tobon, Farah Raheem, Grace S Hwang
Journal of Oncology Pharmacy Practice. 2022-12-01 - 11 citationsDaratumumab for the Treatment of Multiple Myeloma: A Review of Clinical Applicability and Operational Considerations.Justin R Arnall, Kathryn T Maples, R Donald Harvey, Donald C Moore
The Annals of Pharmacotherapy. 2022-08-01
Office
100 Medical Park Drive Northeast
Concord, NC 28025Phone+1 704-403-1370
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
